Inventor · disambiguated record
Lars Fogh Iversen
Also filed as: IVERSEN LARS · IVERSEN LARS F · IVERSEN LARS FOGH
10 granted patents·16 pending applications·204 citations·filing 1999–2022
87Inventor score
Files withNOVO NORDISK AS17BURNHAM INST1CONDE FIEBOES KILLIAN WALDEMAR1NOERBY INGA SIG NIELSEN1NORBY INGA S N1
Top patents by PatentIndex Score
26 records- 0197US6410586B1Modulators of protein tyrosine phosphatases (PTPases)NOVO NORDISK AS·Filed 2001·Granted Jun 25, 2002·78 cites·7 claims
- 0296US6262044B1Modulators of protein tyrosine phosphatases (PTPASES)NOVO NORDISK AS·Filed 1999·Granted Jul 17, 2001·108 cites·10 claims
- 0388US10398782B2MIC-1 compounds and uses thereofNOVO NORDISK AS·Filed 2018·Granted Sep 3, 2019·5 cites·28 claims
- 0479US12006344B2MIC-1 compounds and use thereofNOVO NORDISK AS·Filed 2022·Granted Jun 11, 2024·0 cites·1 claims
- 0578US6951878B2Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)NOVO NORDISK AS·Filed 2002·Granted Oct 4, 2005·7 cites·17 claims
- 0674US7115624B1Method of inhibiting protein tyrosine phosphatase 1B and/or T-cell protein tyrosine phosphatase 4 and/or other PTPases with an Asp residue at position 48NOVO NORDISK AS·Filed 2000·Granted Oct 3, 2006·6 cites·6 claims
- 0768US2023364248A1Mic-1 compounds and uses thereofNOVO NORDISK AS·Filed 2022·Application pending·0 cites
- 0865US2021198331A1Mic-1 compounds and use thereofNOVO NORDISK AS·Filed 2021·Application pending·0 cites
- 0965US2009042272A1Processing of Peptides and ProteinsNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1064US7662935B2Processing of peptides and proteinsNOVO NORDISK AS·Filed 2009·Granted Feb 16, 2010·0 cites·4 claims
- 1162US9534209B2Methods and tools for identification of RSK/MSK kinase inhibitorsUNIV AARHUS·Filed 2013·Granted Jan 3, 2017·0 cites·18 claims
- 1258US8530217B2Processing of peptides and proteinsNOERBY INGA SIG NIELSEN·Filed 2009·Granted Sep 10, 2013·0 cites·5 claims
- 1358US2006286629A1Processing of Peptides and ProteinsNORBY INGA S N·Filed 2006·Application pending·0 cites
- 1453US2024035005A1Lipase variants and compositions comprising such lipase variantsNOVOZYMES AS·Filed 2021·Application pending·0 cites
- 1550US2019248852A1MIC-1 Compounds and Use ThereofNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 1644US2007141662A1Fusion proteins and methods of cleavage of such proteinsBURNHAM INST·Filed 2006·Application pending·0 cites
- 1742US2006188476A1Interleukin 20 (IL-20) and its use in neovascularisationNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 1842US2010197573A1Transglutaminase Mediated Conjugation of Growth HormoneNOVO NORDISK HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 1941US2008182783A1Growth Hormone ConjugatesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 2040US6960610B2Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseasesNOVO NORDISK AS·Filed 2003·Granted Nov 1, 2005·0 cites·51 claims
- 2140US2008064630A1Osteogenic Growth Peptide Fusion ProteinsNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 2239US2008305986A1Multimers of PeptidesCONDE FIEBOES KILLIAN WALDEMAR·Filed 2005·Application pending·0 cites
- 2339US2006257479A1Long-acting molecules in sustained release formulationsNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 2437US2009269843A1Hemopexin fusion proteinsNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 2536US2004082641A1Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseasesFiled 2003·Application pending·0 cites
- 2631US2005054618A1Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseasesFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lars Fogh Iversen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →